Table 1.
Characteristics of patients undergoing pleuroscopy; ASA: American Society of Anesthesiologists; COPD: chronic obstructive pulmonary disease; CAD: coronary artery disease; OSA: obstructive sleep apnea; CRF: chronic respiratory failure; DM: diabetes mellitus; SAH: systemic arterial hypertension; CKD: chronic kidney disease; ILD: interstitial lung disease. Data are presented as mean and standard deviation or absolute number (percentage).
| Group A | Group B | p | |
|---|---|---|---|
| Patients, n | 91 | 116 | |
| Age, years (SD) | 72 (11) | 69 (11) | 0.102 |
| BMI (SD) | 30 (8.72) | 28 (7.45) | 0.083 |
| Male | 62 | 79 | 0.997 |
| Female | 29 | 31 | 0.420 |
| Charlson Comorbidity Index (SD) | 4.27 (2.04) | 1.64 (1.52) | <0.001 |
| SpO2 % basal | 92.44% | 93.07% | 0.138 |
| ASA 3, n (%) | 48 (50%) | 46 (39.66%) | 0.059 |
| ASA 2, n (%) | 48 (50%) | 70 (60.34%) | 0.273 |
| COPD, n (%) | 21 (23.07%) | 7 (6.04%) | 0.001 |
| CAD, n (%) | 20 (21.97%) | 16 (13.79%) | 0.129 |
| OSA, n (%) | 4 (4.39%) | 0 | 0.041 |
| CRF n (%) | 2 (2.19%) | 5 (4.31%) | 0.385 |
| DM, n (%) | 12 (13.18%) | 29 (25%) | 0.028 |
| Arrhythmias, n (%) | 20 (21.97%) | 16 (13.79%) | 0.129 |
| SAH, n (%) | 49 (53.84%) | 0 | <0.001 |
| Heart failure, n (%) | 6 (6.59%) | 13 (11.2%) | 0.239 |
| CKD, n (%) | 9 (9.89%) | 5 (4.31%) | 0.127 |
| Neoplasm, n (%) | 28 (30.76%) | 41(35.34%) | 0.486 |
| Stroke, n (%) | 6 (6.59%) | 8 (6.89%) | 0.931 |
| ILD, n (%) | 3 (3.29%) | 1 (0.86%) | 0.237 |